Elevated antibody levels to periodontopathogens in GCF have been identified and used as support for local antibody synthesis in periodontitis. This study examined both cross-sectional and longitudinal GCF samples for the antigenic specificity of antibody in the fluid. GCF samples were collected from each tooth of 27 periodontitis patients infected with A. actinomycetemcomitans. Levels of IgG antibody in the GCF were assessed by means of an ELISA and compared with serum for determination of local elevations. A proportion of those GCF samples that exhibited significantly elevated antibody were examined by Western immunoblotting to outer membrane antigens from A. actinomycetemcomitans. Homologous sera were also examined for comparison of antibody specificities. Of the sites with elevated IgG antibody, 87% were colonized by A. actinomycetemcomitans; however, 46% of sites with A. actinomycetemcomitans infection did not have elevated antibody. Cross-sectional studies identified a 78 to 100% agreement between the antibody specificities in GCF and those in serum. Additionally, patterns of antibody reactivity in both GCF and serum in the subjects were often very distinctive. Longitudinal alterations in GCF antibody were examined in 15 patients through a monitoring interval of up to 2 years and showed a general conservation of specificities. However, 7/15 patients exhibited a definite acquisition of different antibody specificities during the monitoring. These results describe a relationship between elevated local antibody and A. actinomycetemcomitans infection. Furthermore, the antibody specificities in serum appear to reflect generally the local response to this pathogen.
Asikainen S., Lai C.-H, Alaluusua S., Slots J. (1991). Distribution of Actinobacillus actinomycetemcomitans serotypes in periodontal health and disease. Oral Microbiol Immunol6:115-118.
2.
Berglund SE (1971). Immunoglobulins in human gingiva with specificity for oral bacteria. J Periodontol42:546-551 .
3.
Bolstad AI, Kristoffersen T., Olsen I., Preus HR, Jensen HB, Vasstrand EN, et al. (1990). Outer membrane proteins of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus studied by SDS-PAGE and immunoblotting. Oral Microbiol Immunol5:155-161.
4.
Bragd L., Dahlen G., Wikstrom M., Slots J. (1987). The capability of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, and Bacteroides intermedius to indicate progressive periodontitis; a retrospective study. J Clin Periodontol14:95-99.
5.
Califano JV, Schenkein HA, Tew JG (1989). Immunodominant antigen of Actinobacillus actinomycetemcomitans Y4 in high-responder patients. Infect Immun57:1582-1589.
6.
Califano JV, Schenkein HA, Tew JG (1992). Immunodominant antigens of Actinobacillus actinomycetemcomitans serotype b in early-onset periodontitis patients. Oral Microbiol Immunol7:65-70.
7.
Cappelli DD, Ebersole JL, Kornman KS (1994). Early-onset periodontitis in Hispanic-American adolescents associated with A. actinomycetemcomitans. Community Dent Oral Epidemiol22:116-121.
Ebersole JL, Cappelli D. (1994). Gingival crevicular fluid antibody to Actinobacillus actinomycetemcomitans in periodontal disease. Oral Microbiol Immunol9:335-344.
10.
Ebersole JL, Holt SC ( 1988). Serum antibodies to periodontopathic microorganism: specific induction. In: Periodontology today. Guggenheim B, editor. Basel, Switzerland: S. Karger AG, p. 169.
11.
Ebersole JL, Holt SC ( 1991). Immunological procedures for diagnosis and risk assessment in periodontal diseases. In: Periodontal diseases: markers of disease susceptibility and activity. Cambridge: Cambridge University Press, pp. 203-227.
12.
Ebersole JL, Taubman MA (1994). The protective nature of host responses in periodontal diseases. Periodontol20005:112-141.
13.
Ebersole JL, Taubman MA, Smith DJ, Genco RJ, Frey DE ( 1982). Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to Actinobacillus actinomycetemcomitans. Clin Exp Immunol47:43-52.
14.
Ebersole JL, Taubman MA, Smith DJ, Goodson JM (1984). Gingival crevicular fluid antibody to oral microorganisms I. Method of collection and analysis of antibody. J Periodont Res19:124-130.
15.
Ebersole JL, Taubman MA, Smith DJ (1985a). Local antibody responses in periodontal diseases . J Periodontol56:51-55.
16.
Ebersole JL, Taubman MA, Smith DJ (1985b). Gingival crevicular fluid antibody to oral microorganisms. II. Distribution and specificity of local antibody responses. J Periodont Res20:349-356.
17.
Ebersole JL, Taubman MA, Smith DJ, Frey DE, Haffajee AD, Socransky SS (1987). Human serum antibody responses to oral microorganisms. IV. Correlation with homologous infection. Oral Microbiol Immunol2:53-59.
18.
Ebersole JL, Sandoval M-N., Steffen MJ, Cappelli D. (1991). Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease. Infect Immun59:1795-1802.
19.
Ebersole JL, Cappelli D., Steffen MJ (1992). Characteristics and utilization of antibody measurements in clinical studies of periodontal disease. J Periodontol63:1110-1116.
20.
Ebersole JL, Cappelli D., Sandoval M-N (1994). Subgingival distribution of A. actinomycetemcomitans in periodontitis. J Clin Periodontol21:65-75.
21.
Ebersole JL, Cappelli D., Sandoval M-N., Steffen MJ (1995a). Antigen specificity of serum antibody in A. actinomycetemcomitans infected periodontitis patients. J Dent Res74:658-666.
22.
Ebersole JL, Cappelli D., Steffen MJ (1995b). Longitudinal dynamics of infection and serum antibody in A. actinomycetemcomitans periodontitis. Oral Dis1:129-138.
23.
Ebersole JL, Cappelli D., Steffen MJ, Willmann DE, O'Dell DS (1996a). Host response assessment in recurring periodontitis . J Clin Periodontol23:258-262.
24.
Ebersole JL, Hall EE, Steffen MJ (1996b). Antigenic diversity in the periodontopathogen, Actinobacillus actinomycetemcomitans. Immunol Invest25: 203-214.
25.
Ebersole JL, Steffen MJ, Cappelli D. (1999). Longitudinal human serum antibody responses to outer membrane antigens of Actinobacillus actinomycetemcomitans. J Clin Periodontol26 :732-741.
26.
Farida R., Wilson M., Ivanyi L. (1986). Serum IgG antibodies to lipopolysaccharides in various forms of periodontal disease in man. Arch Oral Biol31:711-715.
27.
Genco RJ, Zambon JJ, Murray PA (1985). Serum and gingival fluid antibodies as adjuncts in the diagnosis of Actinobacillus actinomycetemcomitans-associated periodontal disease. J Periodontol56;41-50.
28.
Genco RJ, Zambon JJ, Christersson LA (1988). The origin of periodontal infections. Adv Dent Res2:245-259.
29.
Gmür R., Hrodek K., Saxer UP, Guggenheim B. (1986). Double-blind analysis of the relation between adult periodontitis and systemic host response to suspected periodontal pathogens . Infect Immun52:768-776.
30.
Haffajee AD, Socransky SS (1994). Microbial etiological agents of destructive periodontal diseases. Periodontol20005:78-111.
31.
Holmberg K., Killander J. (1971). Quantitative determination of immunoglobuline (IgG, IgA and IgM) and identification of IgA-type in the gingival fluid. J Periodont Res6:1-8.
32.
Holt PG, Nelson DJ, McWilliam AS (1995). Population dynamics and function of respiratory tract dendritic cells in the rat. Adv Exp Biol Med378:177-182.
33.
Holt SC, Bramanti TE (1991). Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med2:177-281.
34.
Kinane DF, Mooney J., MacFarlane TW, McDonald M. (1993). Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: correlation with clinical indices. Oral Microbiol Immunol8:65-68.
35.
Lally ET, Baehni PC, McArthur WP (1980). Local immunoglobulin synthesis in periodontal disease. J Periodont Res15:159-164.
36.
Lamster IB, Novak MJ (1992). Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med3:31-60.
37.
Ling TY, Sims TJ, Chen HA, Whitney CW, Moncla BJ, Engel LD, et al. (1993). Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Clin Immunol13:101-112.
38.
Listgarten M., Lai C.-H, Evian CI (1981). Comparative antibody titers to Actinobacillus actinomycetemcomitans in juvenile periodontitis, chronic periodontitis and periodontally healthy subjects. J Clin Periodontol8:155-164.
39.
Liu L., MacPherson GG (1995). Dendritic cells "in vivo": their role in the initiation of intestinal immune responses. Adv Exp Biol Med371(A):271-274.
40.
Mackler BF, Waldrop TC, Schur P., Robertson PB, Levy BM ( 1978). IgG subclasses in human periodontal disease. I. Distribution and incidence of IgG subclass bearing lymphocytes and plasma cells. J Periodont Res13:109-119.
41.
McArthur WP, Clark WB (1993). Specific antibodies and their potential role in periodontal diseases. J Periodontol64 :807-818.
42.
Mombelli A., Gmür R., Gobbi C., Lang NP ( 1994). Actinobacillus actinomycetemcomitans in adult periodontitis. I. Topographic distribution before and after treatment. J Periodontol65:820-826.
43.
Moughal NA, Adonogianaki E., Kinane DF (1992). Langerhans cell dynamics in human gingiva during experimentally induced inflammation. J Biol Buccale20:163-167.
44.
Nakano Y., Inai Y., Yamashita Y., Nagaoka S., Kusuzaki-Nagira T., Nishihara T., et al. (1995). Molecular and immunological characterization of a 64-kDa protein of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol10:151-159.
45.
Novak MJ, Cohen HJ (1991). Depolarization of polymorphonuclear leukocytes by Porphyromonas (Bacteroides) gingivalis 381 in the absence of respiratory burst activation. Infect Immun59:3134-3142.
46.
Ogawa T., Tarkowski A., McGhee ML, Moldoveanu Z., Mestecky J., Hirsch HZ, et al. (1989). Analysis of human IgG and IgA subclass antibody secreting cells from localized chronic inflammatory tissue. J Immunol142: 1150-1158.
47.
Page RC, Sims TJ, Engel LD, Moncla BJ, Bainbridge B., Stray J., et al. (1991). The immunodominant outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype-specific high-molecular-mass carbohydrate moiety of lipopolysaccharide. Infect Immun59:3451-3462.
48.
Preus HR, Zambon JJ, Dunford RG, Genco RJ (1994). The distribution and transmission of Actinobacillus actinomycetemcomitans in families with established adult periodontitis. J Periodontol65:2-7.
49.
Ranney RR (1991). Immunologic mechanisms of pathogenesis in periodontal diseases: an assessment. J Periodont Res26:243-254.
50.
Reinhardt RA, McDonald TL, Bolton RW, Dubois LM, Kaldahl WB (1989). IgG subclasses in gingival crevicular fluid from active versus stable periodontal sites. J Periodontol60:44-50.
51.
Saito A., Hosaka Y., Nakagawa T., Yamada S., Okuda K. (1993). Relative avidity of serum immunoglobulin G antibody for the fimbria antigen of Actinobacillus actinomycetemcomitans in patients with adult periodontitis. Infect Immun61:332-334.
52.
Seymour GJ, Powell RN, Davies WI (1979). Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease: an hypothesis. J Clin Periodontol6:267-277.
53.
Sims TJ, Moncla BJ, Darveau RP, Page RC ( 1991). Antigens of Actinobacillus actinomycetemcomitans recognized by patients with juvenile periodontitis and periodontally normal subjects . Infect Immun59:913-924.
54.
Sjostrom K., Ou J., Whitney C., Johnson B., Darveau R., Engel D., et al. (1994). Effect of treatment on titer, function, and antigen recognition of serum antibodies to Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis. Infect Immun62:145-151.
55.
Slots J., Genco RJ (1984). Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res63:412-421.
56.
Slots J., Listgarten MA (1988). Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol15:85-93.
57.
Smith DJ, Gadalla LM, Ebersole JL, Taubman MA (1985). Gingival crevicular fluid antibody to oral microorganisms. III. Association of gingival homogenate and gingival crevicular fluid antibody levels. J Periodont Res20:357-367.
58.
Socransky SS, Haffajee AD (1994). Evidence of bacterial etiology: a historical perspective . Periodontol20005:7-25.
59.
Steubing PM, Mackler BF, Schur PH, Levy BM ( 1982). Humoral studies of periodontal disease. I. Characterization of immunoglobulins quantitated from cultures of gingival tissue. Clin Immunol Immunopathol22:32-43.
60.
Tew JG, Marshall DR, Burmeister JA, Ranney RR (1985a). Relationship between gingival crevicular fluid and serum antibody titers in young adults with generalized and localized periodontitis . Infect Immun49:487-493.
61.
Tew JG, Marshall DR, Moore WE, Best AM, Palcanis KG, Ranney RR (1985b). Serum antibody reactive with predominant organisms in the subgingival flora of young adults with generalized severe periodontitis . Infect Immun48:303-311.
Watanabe H., Marsh PD, Ivanyi L. (1989). Antigens of Actinobacillus actinomycetemcomitans identified by immunoblotting with sera from patients with localized human juvenile periodontitis and generalized severe periodontitis. Arch Oral Biol34:649-656.
64.
Wilson ME (1991). IgG antibody response of localized juvenile periodontitis patients to the 29 kilodalton outer membrane protein of Actinobacillus actinomycetemcomitans . J Periodontol62:211-218.
65.
Wilton JM, Bampton JL, Hurst TJ, Caves J., Powell JR (1993). Interleukin-1β and IgG subclass concentrations in gingival crevicular fluid from patients with adult periodontitis. Arch Oral Biol38:55-60.
66.
Zambon JJ, Umemoto T., De Nardin E., Nakazawa F., Christersson LA, Genco RJ (1988). Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res2:269-274.
